Traders sold shares of Humana Inc. (NYSE:HUM) on strength during trading hours on Monday. $33.96 million flowed into the stock on the tick-up and $72.72 million flowed out of the stock on the tick-down, for a money net flow of $38.76 million out of the stock. Of all equities tracked, Humana had the 16th highest net out-flow for the day. Humana traded up $2.08 for the day and closed at $249.36

A number of equities research analysts have recently commented on the company. UBS AG reissued a “neutral” rating and issued a $250.00 target price (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. Cantor Fitzgerald reissued a “neutral” rating and issued a $223.00 target price (up from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Morgan Stanley increased their target price on Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $257.00 target price on shares of Humana in a research note on Friday, August 4th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the company. Humana has a consensus rating of “Hold” and an average target price of $244.35.

The firm’s 50-day moving average price is $241.05 and its 200-day moving average price is $224.57. The stock has a market cap of $36.04 billion, a P/E ratio of 20.51 and a beta of 0.91.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same quarter in the previous year, the firm posted $2.30 EPS. On average, analysts forecast that Humana Inc. will post $11.55 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.64%. Humana’s dividend payout ratio (DPR) is presently 13.06%.

In other news, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the transaction, the chief executive officer now owns 80,086 shares of the company’s stock, valued at approximately $20,172,061.68. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the transaction, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at approximately $3,421,920. The disclosure for this sale can be found here. In the last three months, insiders sold 41,406 shares of company stock valued at $10,355,086. Insiders own 0.80% of the company’s stock.

Several institutional investors have recently modified their holdings of the stock. Quantitative Systematic Strategies LLC bought a new position in shares of Humana during the first quarter valued at about $375,000. Columbus Circle Investors boosted its position in shares of Humana by 97.4% in the first quarter. Columbus Circle Investors now owns 13,623 shares of the insurance provider’s stock valued at $2,808,000 after buying an additional 6,722 shares during the period. State of Alaska Department of Revenue bought a new position in shares of Humana during the first quarter valued at about $342,000. Hermes Investment Management Ltd. boosted its position in shares of Humana by 0.9% in the first quarter. Hermes Investment Management Ltd. now owns 78,911 shares of the insurance provider’s stock valued at $16,267,000 after buying an additional 700 shares during the period. Finally, Mn Services Vermogensbeheer B.V. boosted its position in shares of Humana by 4.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 3,976 shares of the insurance provider’s stock valued at $766,000 after buying an additional 158 shares during the period. 99.13% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Traders Sell Shares of Humana Inc. (HUM) on Strength (HUM)” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/21/traders-sell-shares-of-humana-inc-hum-on-strength-hum-2.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.